| ¿µ¹® | carbohydrate | ÇÑ±Û | ź¼öȹ° |
|---|---|---|---|
| ¼³¸í | ź¼Ò¿Í ¹°ºÐÀÚ·Î ÀÌ·ç¾îÁø À¯±âÈÇÕ¹°. »ï´ë¿µ¾ç¼Ò °¡¿îµ¥ Çϳª·Î, ³ì»ö½Ä¹°ÀÇ ±¤ÇÕ¼ºÀ¸·Î »ý±ä´Ù. Æ÷µµ´ç, °ú´ç, ³ì¸» µûÀ§°¡ ÀÖ´Ù. ÀϹÝÀûÀ¸·Î ź¼Ò-¼ö¼Ò-»ê¼ÒÀÇ ¼¼ ¿ø¼Ò·Î ÀÌ·ç¾îÁö´Â ÈÇÕ¹°·Î, ³ÐÀº ¶æÀ¸·Î´Â ´ç·ù-´çÁú°ú °°Àº ¶æÀ¸·Î ¾²ÀδÙ. ÀϹݽÄ(Cn(H2O)nÀÌ ¸¶Ä¡ ź¼Ò¿Í ¹°ºÐÀÚ(H2O)·Î ÀÌ·ç¾îÁ® ÀÖ´Â °Íó·³ º¸À̱⠶§¹®¿¡ ÀÌ·± À̸§ÀÌ ºÙ¾ú´Ù. ±×¸®°í »ê¼Ò ¿øÀÚ¼ö°¡ ÀϹݽĺ¸´Ù Çϳª ÀûÀº °Í, Áú¼Ò¿øÀÚ¸¦ ÇÔÀ¯ÇÏ´Â °Í, ȲÈÇÕ¹°À» ÇÔÀ¯ÇÏ´Â °Íµµ ź¼öȹ°¿¡ Æ÷ÇÔ½ÃŲ´Ù. ÈÇÐÀûÀ¸·Î´Â ´Ù°¡ ¾ËÄÚ¿ÃÀÇ ¾Ëµ¥È÷µå ¶Ç´Â ÄÉÅæ ¹× ±× À¯µµÃ¼ÀÇ ÃÑĪÀÌ´Ù. |
||
| ¿µ¹® | premature infant | ÇÑ±Û | ¹Ì¼÷¾Æ, Á¶»ê¾Æ |
|---|---|---|---|
| ¼³¸í | »ýÁ¸°¡´É ÇѰè ÀÌÈÄ¿¡, Á¤±â Ãâ»êÀÇ ½Ã±â ÀÌÀü¿¡ ÀÚ¿¬ÀûÀ̰ųª ÀΰøÀûÀ¸·Î ºÐ¸¸ÇÏ´Â °ÍÀ» Á¶»êÀ̶ó°í Çϸç, ±× °á°ú ÅÂ¾î³ ¾ÆÀ̸¦ Á¶»ê¾Æ¶ó°í ¸»ÇÑ´Ù. WHO¿¡¼´Â 28~37ÁÖ¿¡ ÅÂ¾î³ ¾Æ±â¶ó°í Á¤ÀÇÇϰí ÀÖ´Ù. ÇöÀç »ýÁ¸°¡´É ÇѰè´Â ÀÇ·á±â¼úÀÇ Áøº¸¿¡ ÀÇÇØ ±× ÇѰ迪ÀÌ ³ÐÇôÁö°í ÀÖ´Ù. Á¶»ê¾ÆÀÇ ´ëºÎºÐÀº ÀúüÁß¾Æ(2,500g ÀÌÇÏ)·Î Ãâ»ýÇϱ⠶§¹®¿¡ °¢ Àå±â±â´ÉÀÌ ÃæºÐÇÏ°Ô ¼º¼÷µÇ¾î ÀÖÁö ¾Ê¾Æ »ýÈÄ¿¡ È£Èí, °£, ÄáÆÏ µîÀÇ ±â´ÉÀå¾Ö¸¦ ¹ß»ýÇÏ´Â ÀÏÀÌ ¸¹´Ù. º¸À°±â¿¡ ÀÇÇÑ °ü¸®°¡ ÇÊ¿äÇÑ °æ¿ìµµ ÀÖ´Ù. ¾î¸®°Å³ª ³ªÀÌ ¸¹Àº ÀÓºÎÀÇ Ãʻ꿡 ¸¹´Ù. |
||
| ¿µ¹® | newborn infant | ÇÑ±Û | ½Å»ý¾Æ |
|---|---|---|---|
| ¼³¸í | ºÐ¸¸ Á÷ÈĺÎÅÍ µ¶¸³µÈ ÀÚ±ÃÀÇ »ýȰÀ» ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» ȹµæÇÒ ¶§±îÁöÀÇ ¾ÆÀÌ. ½Å»ý¾Æ´Â »ýÈÄ 4ÁÖÀϱîÁö¸¦ ¸»ÇÑ´Ù. ÀÌ ±â°£¿¡ ½Å»ý¾Æ´Â ¸ðüÀÇ Å ¾È¿¡¼ ÀÚµ¿ÀûÀ¸·Î »ê¼Ò³ª ¿µ¾çÀ» ¹Þ°í ÀÖ´ø »óÅ¿¡¼ ÀÚ·ÂÀ¸·Î È£ÈíÀ̳ª ¿µ¾ç ¼·Ã븦 ÇÏ°Ô µÇ´Â ±Þ°ÝÇÑ º¯È°¡ ÀϾ°í, ÀÌ¿¡ µû¶ó¼ ÃʱâÀÇ Ã¼¿ÂÀÇ °ÇÏ, »ý¸®Àû üÁßÀÇ °¨¼Ò, ½Å»ý¾ÆÈ²´Þ, ÅÈÁÙÀÇ Å»¶ô µîÀÇ ¿©·¯ Çö»óÀÌ ÀϾÙ. °¨°¢¸é¿¡¼´Â ¿µ¾ç ¼·Ã븦 À§ÇÑ ÈíÀιݻç´Â Àß ¹ß´ÞµÇ¾î ÀÖÀ¸³ª, ¹Ì°¢Àº ´ë°ÀÇ ¸ÀÀÇ ÆÇº°, Èİ¢Àº °ÇÑ ¾ÇÃë¿¡ ´ëÇÑ ¹ÝÀÀ, ½Ã°¢Àº ¸í¾ÏÀ» ÆÇº°ÇÏ´Â Á¤µµÀ̸ç, û°¢Àº »ýÈÄ 1ÁÖÀϰæ±îÁö´Â °ÅÀÇ ¹ÝÀÀÀ» ³ªÅ¸³»Áö ¾Ê´Â´Ù. |
||
| ¿µ¹® | infant | ÇÑ±Û | ¿µ¾Æ, À¯¾Æ, Á¥¸ÔÀÌ |
|---|---|---|---|
| ¼³¸í | ½Å»ý¾Æ¸¦ Æ÷ÇÔÇØ Ãâ»ý ÈÄ 1³â±îÁöÀÇ ¾î¸°À̸¦ ¸»Çϸç ÀÌ ±â°£À» ¿µ¾Æ±â¶ó ºÎ¸¥´Ù. ½Åü¹ßÀ° ¹× ¿îµ¿±â´ÉÀÇ ¹ß´ÞÀÌ ¸Å¿ì Ȱ¹ßÇÑ ½Ã±âÀÌ´Ù. ÀÌ ½Ã±â´Â ½Å»ý¾Æ ¶§ºÎÅÍ °è¼ÓÇØ¼ ȯ°æ¿¡ ÀûÀÀÇØ °¡´Â Áß¿äÇÑ ½Ã±âÀÌ´Ù. Á¥´Ï°¡ ³ª¿À¸ç ¸é¿ª±â´ÉÀÇ È°¼ºÈ, ¹Ý»çÀÇ ¼Ò½Ç°ú ¼öÀǿÀÇ ¹ß´Þ, °¨°¢(½Ã°¢, û°¢, Ã˰¢) ±â´ÉÀÇ ¹ß´Þ, üÁß°ú ŰÀÇ Áõ°¡¸¦ È®ÀÎÇÒ ¼ö ÀÖ´Ù. üÁßÀº 3°³¿ù¿¡ 2¹è, 1³â¿£ 3¹è°¡ µÇ¸ç, Ű´Â 1³â¿¡ ¾à 27cm ÀÚ¶õ´Ù. |
||
| ¿µ¹® | sudden infant death syndrome | ÇÑ±Û | ¿µ¾Æ±Þ»çÁõÈıº |
|---|---|---|---|
| ¼³¸í | ÇÑ »ì ÀÌÇÏÀÇ °Ç°ÇÑ ¾Æ±â°¡ ¾Æ¹«·± Á¶ÁüÀ̳ª ¿øÀÎ ¾øÀÌ °©Àڱ⠻ç¸ÁÇßÀ» °æ¿ì¿¡ ³»¸®´Â Áø´ÜÀÌ´Ù. ÀÌ ÁõÈıºÀº »ýÈÄ 1~4°³¿ù »çÀÌ¿¡ °¡Àå ¸¹ÀÌ ¹ß»ýÇϸç, ´ëºÎºÐ ¹ã 10½Ã¿¡¼ ¿ÀÀü 10½Ã »çÀÌ¿¡ ¹ß»ýÇÑ´Ù. Á¶»êÇϰųª ºÎ¸ð°¡ Èí¿¬ÀÚÀÏ °æ¿ì, 20¼¼ ÀÌÇÏ »ê¸ðÀÇ ÃÊ»ê, ÀÓ½ÅÀü °Ç°°ü¸®¿¡ ¼ÒȦÇÑ »ê¸ð¿¡°Ô¼ ÅÂ¾î³ ¿µ¾Æ¿¡°Ô¼ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ÀÌ ÁõÈıºÀ¸·Î »ç¸ÁÇÑ ¿µ¾ÆÀÇ ÇüÁ¦ÀÏ °æ¿ì ÀϹÝÀûÀÎ ¿µ¾Æº¸´Ù °É¸± È®·üÀÌ ³ôÀº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. |
||
| ADI | Academy of Dentistry International; acceptable daily intake; AIDS-defining illness; allowable daily ... |
|---|---|
| DPI | daily permissible intake; days post inoculation; dietary protein intake; diphtheria-pertussis immuni... |
| IMR | individual medical record; infant mortality rate; infant mortality risk; Institute for Medical Resea... |
| IDA | 1) Imino-Diacetic Acid 2) Iron Deficiency Anemia &nb... |
| I & O | Intake & Output; ¼·Ãë·®°ú ¹è¼³·® |
| BSID | Bayley Scale of Infant Development |
|---|---|
| IMR | Infant Mortality Rate |
| NMIHS | National Maternal and Infant Health Survey |
| SID | Sudden Infant Death |
| SIDS | Suddern Infant Death Syndrome |
| acceptable daily intake | <pharmacology> This is an estimate of the amount of a substance in food that can be ingested daily over a lifetime by humans without appreciable health risk. The concept of the acceptable daily intake has been developed principally by who and FAO and is relevant to chemicals such as additives to foods, residues of pesticides and veterinary drugs in foods. Acceptable daily intakes are derived from laboratory toxicity data, and from human experiences of such chemicals when this is available, and incorporate a safety factor. The acceptable daily intake is thus an estimate of the amount of a substance in food that can be ingested over a lifetime by humans without significant risk to health (for contaminants in food and drinking water, tolerable intakes - daily or weekly - are used). See: tolerable daily intake. (15 Jan 1998) |
|---|---|
| tolerable daily intake | TDIs are applied to chemical contaminants in food and drinking water. The presence of contaminants is unwanted and they have no useful function, differing from additives and residues where there is or was deliberate use resulting in their presence. TDIs are calculated on the basis of laboratory toxicity data with the application of uncertainty factors. A TDI is therefore an estimate of the amount of a substance (contaminant) in food or drinking water that can be ingested daily over a lifetime without a significant health risk. (09 Oct 1997) |
| energy intake | Total number of calories taken in daily whether ingested or by parenteral routes. (12 Dec 1998) |
| antigens, tumour-associated, carbohydrate | Carbohydrate antigens expressed by malignant tissue. They are useful as tumour markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies. (12 Dec 1998) |
| carbohydrate | <biochemistry> Very abundant compounds, usually an aldehyde or ketone derivative of a polyhydric alcohol, particularly of the pentahydric and hexahydric alcohols. They are so named because the hydrogen and oxygen are usually in the proportion to form water with the general formula Cn(H2O)n. The most important carbohydrates are the starches, sugars, celluloses and gums. They are classified into mono, di, tri, poly and heterosaccharides. The smallest are monosaccharides like glucose whereas polysaccharides such as starch, cellulose or glycogen can be large and indeterminate in length. (08 Oct 1997) |
| carbohydrate conformation | The characteristic 3-dimensional shape of a carbohydrate. (12 Dec 1998) |
| carbohydrate-deficient glycoprotein syndrome | <syndrome> An inborn error of carbohydrate metabolism manifesting as a genetic multisystem disorder of autosomal recessive inheritance. A predominant feature is severe central and peripheral nervous system involvement resulting in psychomotor retardation, seizures, cerebellar ataxia, and other symptoms which include growth retardation, retinitis pigmentosa, hypothyroidism, and fatty liver. The notable biochemical feature is the deficiency of a large number of blood glycoproteins and decreased activities of various blood coagulation factors. (12 Dec 1998) |
| carbohydrate dehydrogenases | <enzyme> Reversibly catalyze the oxidation of a hydroxyl group of carbohydrates to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted. Registry number: EC 1.1. (12 Dec 1998) |
| carbohydrate epimerases | <enzyme> Enzymes that catalyze the epimerization of chiral centres within carbohydrates or their derivatives. Registry number: EC 5.1.3 (12 Dec 1998) |
| carbohydrate-induced hyperlipaemia | type III familial hyperlipoproteinaemia, type IV familial hyperlipoproteinaemia |
| carbohydrate loading | A procedure popular with long-distance runners and other athletes of filling muscles with a large glycogen pool prior to an athletic event; often, the athlete consumes very few carbohydrates for three days followed by a largely carbohydrate diet for the last three days before the event. (05 Mar 2000) |
| carbohydrate metabolism | <biochemistry> The breakdown of starches and sugars into smaller units that can be used by the body for energy. (27 Sep 1997) |
| carbohydrate sequence | The sequence of carbohydrates within polysaccharides, glycoproteins, and glycolipids. (12 Dec 1998) |
| carbohydrate utilization test | A test for the definitive identification of clinically important yeasts and yeastlike organisms. (05 Mar 2000) |
| C carbohydrate antigen | An antigen found in the cell wall of Streptococcus pneumoniae. See: beta-haemolytic streptococci. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|